The US Food and Drug Administration (FDA) recently finalized an order classifying in vivo cured intramedullary fixation rods as class II devices. The final order—effective as of 8 June—is aimed at ...
(a)-(d): The bone marrow biopsy shows mild hypercellularity (a, H&E 200×) and mild to moderate fibrosis (b, Reticulin stain, 200×). CD79a (c, 200×) and CD3 (d, 200×) immunostains highlight lymphoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results